| Product Code: ETC10765529 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Pemetrexed Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Pemetrexed Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Pemetrexed Market - Industry Life Cycle |
3.4 Mexico Pemetrexed Market - Porter's Five Forces |
3.5 Mexico Pemetrexed Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Mexico Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 Mexico Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2021 & 2031F |
3.8 Mexico Pemetrexed Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Mexico Pemetrexed Market Revenues & Volume Share, By Administration Route, 2021 & 2031F |
4 Mexico Pemetrexed Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lung cancer in Mexico |
4.2.2 Growing awareness about the benefits of pemetrexed in cancer treatment |
4.2.3 Rising healthcare expenditure and infrastructure development in Mexico |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Mexico |
4.3.2 Availability of alternative cancer treatments in the market |
4.3.3 High cost associated with pemetrexed therapy |
5 Mexico Pemetrexed Market Trends |
6 Mexico Pemetrexed Market, By Types |
6.1 Mexico Pemetrexed Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Mexico Pemetrexed Market Revenues & Volume, By Indication, 2021 - 2031F |
6.1.3 Mexico Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2021 - 2031F |
6.1.4 Mexico Pemetrexed Market Revenues & Volume, By Mesothelioma, 2021 - 2031F |
6.1.5 Mexico Pemetrexed Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.1.6 Mexico Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.1.7 Mexico Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2021 - 2031F |
6.2 Mexico Pemetrexed Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Mexico Pemetrexed Market Revenues & Volume, By Antifolate, 2021 - 2031F |
6.2.3 Mexico Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2021 - 2031F |
6.2.4 Mexico Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2021 - 2031F |
6.2.5 Mexico Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2021 - 2031F |
6.2.6 Mexico Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2021 - 2031F |
6.3 Mexico Pemetrexed Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 Mexico Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2021 - 2031F |
6.3.3 Mexico Pemetrexed Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.3.4 Mexico Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.3.5 Mexico Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.3.6 Mexico Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.4 Mexico Pemetrexed Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Mexico Pemetrexed Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Mexico Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.4.4 Mexico Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.5 Mexico Pemetrexed Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Mexico Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.5 Mexico Pemetrexed Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 Mexico Pemetrexed Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.5.3 Mexico Pemetrexed Market Revenues & Volume, By Injection, 2021 - 2031F |
6.5.4 Mexico Pemetrexed Market Revenues & Volume, By IV Infusion, 2021 - 2031F |
6.5.5 Mexico Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.5.6 Mexico Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2021 - 2031F |
7 Mexico Pemetrexed Market Import-Export Trade Statistics |
7.1 Mexico Pemetrexed Market Export to Major Countries |
7.2 Mexico Pemetrexed Market Imports from Major Countries |
8 Mexico Pemetrexed Market Key Performance Indicators |
8.1 Number of clinical trials and research studies on pemetrexed in Mexico |
8.2 Adoption rate of pemetrexed in cancer treatment centers |
8.3 Number of healthcare facilities offering pemetrexed therapy |
8.4 Patient adherence and compliance rates to pemetrexed treatment protocols |
9 Mexico Pemetrexed Market - Opportunity Assessment |
9.1 Mexico Pemetrexed Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Mexico Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 Mexico Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2021 & 2031F |
9.4 Mexico Pemetrexed Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Mexico Pemetrexed Market Opportunity Assessment, By Administration Route, 2021 & 2031F |
10 Mexico Pemetrexed Market - Competitive Landscape |
10.1 Mexico Pemetrexed Market Revenue Share, By Companies, 2024 |
10.2 Mexico Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here